Welcome to our dedicated page for Globe Life SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Globe Life Inc. (NYSE: GL) filings with the U.S. Securities and Exchange Commission, along with AI-generated explanations to help interpret key disclosures. Globe Life is an insurance holding company focused on life and supplemental health insurance, annuities and related investment activities, and its SEC filings offer detailed insight into these operations.
Investors can review current reports on Form 8-K, where Globe Life reports material events such as quarterly earnings releases, changes to executive retirement or compensation plans and significant financing arrangements. For example, recent 8-K filings describe the company’s second and third quarter financial results, an amendment to the Supplemental Executive Retirement Plan and the creation of a pre-capitalized trust securities (P-CAP) program that provides contingent liquidity through senior notes.
Filings also document corporate governance and executive arrangements, including early retirement reduction factors and vesting rules under the SERP in connection with change-of-control protection periods. These disclosures help clarify how Globe Life structures retirement benefits and severance protections for certain executives.
Through this page, users can track debt and capital structure–related disclosures, such as facility agreements, trust arrangements and obligations tied to senior notes and pre-capitalized trust securities. These items illustrate how Globe Life manages liquidity and long-term financing in support of its insurance and investment activities.
The platform supplements raw filings with AI-powered summaries that highlight important sections, explain technical terms and distinguish between GAAP and non-GAAP measures when referenced in attached earnings materials. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while structured data views make it easier to locate information related to executive plans, financing arrangements and reported results.
Globe Life Inc. Co‑Chairman & CEO James Matthew Darden reported an option exercise and related share sale. He exercised 18,318 shares of common stock via employee stock options at $100.7400 per share, then completed an open‑market sale of 18,318 shares at an average price of $145.1029 per share.
Footnotes state the sale prices ranged from $145.00 to $145.275 per share. After these transactions, he directly holds 58,451.4598 shares of common stock, plus 4,185.5850 shares held indirectly through a 401(k) Plan, and 26,682 employee stock options remain outstanding.
GLOBE LIFE INC. executive vice president and chief strategy officer Michael Clay Majors reported an exercise-and-sell transaction in company stock. He exercised 34,000 employee stock options at an exercise price of $98.32 per share, converting them into common shares.
On the same date, he completed open-market sales totaling 34,000 common shares in multiple trades. Reported sale prices include specific executions such as $154.4305 per share, with footnotes noting price ranges from $152.325 to $155.05 per share across the different sale tranches.
GLOBE LIFE INC. senior vice president and chief accounting officer Michael Shane Henrie exercised employee stock options and sold common shares. He exercised options for 3,065 shares of common stock at a conversion price of $120.49 per share, fully eliminating this option position.
On the same date, he completed open-market sales totaling 3,591 shares of common stock at prices around $154.35–$154.89 per share. After these transactions, he directly holds 3,449.0833 common shares and indirectly holds 158.2240 common shares through a 401(k) plan.
Globe Life Inc. reported a Form 144 notice for the sale of 34,000 shares of Common Stock, relating to a stock option exercise reported on 04/24/2026. The filing lists prior sales on 02/06/2026 of 27,000 shares for $3,968,653.77 and 3,000 shares for $438,169.44. The broker listed is Apex Clearing in Dallas. The filing states proceeds are from a Stock Option Exercise.
Globe Life submitted a Rule 144 notice reporting insider disposition activity of common stock related to stock option exercises. The filing lists sales of 9,527 shares for $1,375,110.03 on 02/27/2026 and 18,318 shares for $2,657,994.92 on 03/04/2026.
Globe Life Inc. reported solid first quarter 2026 growth, with net income of $3.39 per diluted share, up from $3.01 a year earlier, and net operating income of $3.43 per diluted share, up from $3.07. Total premium revenue rose to $1.27 billion, a 6% increase, driven by 3% growth in life premium and 13% growth in health premium.
Return on equity was strong: net income ROE reached 17.9%, while net operating income ROE excluding AOCI was 14.0%. Book value per share was $77.03, up 19%, and $98.56 excluding AOCI, up 12%. Life net sales increased 6% and health net sales 58%, with notable gains in the United American and Family Heritage divisions.
The company repurchased 1.4 million shares for $203 million at an average price of $141.24 and raised full-year 2026 earnings guidance to a range of $15.40–$15.90 per share, an increase of $0.35 at the midpoint.
GLOBE LIFE INC. EVP & Chief Talent Officer Rebecca E. Zorn exercised stock options and sold shares in a linked set of transactions. She exercised 8,800 Employee Stock Options at an exercise price of $98.32 per share, receiving an equal number of Globe Life common shares.
On the same date, she sold a total of 8,800 common shares in open‑market transactions at prices ranging from about $135.23 to $137.88 per share, including blocks at $135.6593, $136.7147, and $137.4038. After these transactions, she directly held 17,797.0997 Globe Life common shares. Footnotes state detailed price breakdowns are available upon request.
Globe Life Inc receives a Schedule 13G/A amendment from The Vanguard Group reporting that, after an internal realignment, Vanguard and its disaggregated subsidiaries report separate beneficial ownership under SEC Release No. 34-39538. The filing states amount beneficially owned: 0 shares (0%) and lists the redelegation of reporting among Vanguard entities effective 01/12/2026. The amendment is signed by Vanguard's Head of Global Fund Administration on 03/26/2026.
Phillips Sandra L. reported acquisition or exercise transactions in this Form 4 filing.
GLOBE LIFE INC. director Sandra L. Phillips reported receiving a grant or award of 1,174 shares of Common Stock on March 20, 2026 at no purchase price. After this award, she directly holds 1,174 shares of Globe Life common stock, with no indirect shares reported as remaining.